Min-Yu Chang

646 total citations
30 papers, 366 citations indexed

About

Min-Yu Chang is a scholar working on Nephrology, Molecular Biology and Physiology. According to data from OpenAlex, Min-Yu Chang has authored 30 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Nephrology, 5 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Min-Yu Chang's work include Dialysis and Renal Disease Management (15 papers), Chronic Kidney Disease and Diabetes (5 papers) and Obstructive Sleep Apnea Research (3 papers). Min-Yu Chang is often cited by papers focused on Dialysis and Renal Disease Management (15 papers), Chronic Kidney Disease and Diabetes (5 papers) and Obstructive Sleep Apnea Research (3 papers). Min-Yu Chang collaborates with scholars based in Taiwan, Belgium and Germany. Min-Yu Chang's co-authors include Yi‐Che Lee, Li‐Chun Ho, Ying-Chieh Tsai, Chien-Chen Wu, Yuan‐Yow Chiou, Hung‐Hsiang Liou, Shih‐Yuan Hung, Hsi‐Hao Wang, Hao‐Kuang Wang and Sheng‐Hsiang Lin and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Min-Yu Chang

30 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min-Yu Chang Taiwan 11 90 88 82 56 55 30 366
Aleksandra Wyczałkowska-Tomasik Poland 10 148 1.6× 113 1.3× 47 0.6× 47 0.8× 34 0.6× 35 447
Angie D. Fulford United States 7 68 0.8× 131 1.5× 18 0.2× 124 2.2× 31 0.6× 14 494
Martine Laville France 12 123 1.4× 184 2.1× 22 0.3× 123 2.2× 16 0.3× 26 516
Jean‐Pierre Ferré France 9 49 0.5× 75 0.9× 85 1.0× 141 2.5× 61 1.1× 11 439
Triantafillia Dimitriou Germany 8 73 0.8× 243 2.8× 269 3.3× 15 0.3× 28 0.5× 8 552
Anjuman Ara Mimi China 6 296 3.3× 85 1.0× 40 0.5× 25 0.4× 32 0.6× 6 422
Ömer Azal Türkiye 12 64 0.7× 28 0.3× 32 0.4× 58 1.0× 32 0.6× 38 412
A. E. Lambert Belgium 11 150 1.7× 122 1.4× 52 0.6× 175 3.1× 30 0.5× 19 590
Özgür Yörük Türkiye 13 35 0.4× 89 1.0× 12 0.1× 126 2.3× 87 1.6× 50 449
S. Güler Türkiye 14 33 0.4× 81 0.9× 15 0.2× 43 0.8× 21 0.4× 33 558

Countries citing papers authored by Min-Yu Chang

Since Specialization
Citations

This map shows the geographic impact of Min-Yu Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min-Yu Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min-Yu Chang more than expected).

Fields of papers citing papers by Min-Yu Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min-Yu Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min-Yu Chang. The network helps show where Min-Yu Chang may publish in the future.

Co-authorship network of co-authors of Min-Yu Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Min-Yu Chang. A scholar is included among the top collaborators of Min-Yu Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min-Yu Chang. Min-Yu Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Yu‐Ling, Sheng‐Hsiang Lin, Hsi‐Hao Wang, et al.. (2025). Role of Metformin in Preventing New-Onset Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus. Pharmaceuticals. 18(1). 95–95. 2 indexed citations
2.
Chang, Min-Yu, et al.. (2023). Neuroprotective Effects of Lactobacillus plantarum PS128 in a Mouse Model of Parkinson’s Disease: The Role of Gut Microbiota and MicroRNAs. International Journal of Molecular Sciences. 24(7). 6794–6794. 30 indexed citations
3.
Lee, Yi‐Che, Chi‐Wei Lin, Li‐Chun Ho, et al.. (2023). All-Cause Standardized Mortality Ratio in Hemodialysis and Peritoneal Dialysis Patients: A Nationwide Population-Based Cohort Study. International Journal of Environmental Research and Public Health. 20(3). 2347–2347. 2 indexed citations
4.
Chen, Tai-Ying, Chien-Chen Wu, Min-Yu Chang, et al.. (2022). Safety Evaluation and Anti-Inflammatory Efficacy of Lacticaseibacillus paracasei PS23. International Journal of Molecular Sciences. 24(1). 724–724. 29 indexed citations
5.
Chang, Min-Yu, Hsi‐Hao Wang, Li‐Hung Chen, et al.. (2022). A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage. Journal of Visualized Experiments. 6 indexed citations
6.
Chang, Min-Yu, Hsi‐Hao Wang, Li‐Hung Chen, et al.. (2022). A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage. Journal of Visualized Experiments. 2 indexed citations
7.
Lin, Ming‐Yen, Min-Yu Chang, Pei-Yu Wu, et al.. (2021). Multidisciplinary care program in pre-end-stage kidney disease from 2010 to 2018 in Taiwan. Journal of the Formosan Medical Association. 121. S64–S72. 12 indexed citations
8.
Cheng, Fong‐Yu, Yuan‐Yow Chiou, Shih‐Yuan Hung, et al.. (2021). Novel Application of Magnetite Nanoparticle-Mediated Vitamin D3 Delivery for Peritoneal Dialysis-Related Peritoneal Damage. International Journal of Nanomedicine. Volume 16. 2137–2146. 9 indexed citations
9.
Hung, Shih‐Yuan, Tsun‐Mei Lin, Hung‐Hsiang Liou, et al.. (2021). Association between ADAMTS13 deficiency and cardiovascular events in chronic hemodialysis patients. Scientific Reports. 11(1). 22816–22816. 3 indexed citations
10.
Chen, Chih‐Ming, et al.. (2021). Lactobacillus plantarum PS128 Promotes Intestinal Motility, Mucin Production, and Serotonin Signaling in Mice. Probiotics and Antimicrobial Proteins. 14(3). 535–545. 36 indexed citations
11.
Liou, Hung‐Hsiang, Chin‐Chi Kuo, Ming‐Hsien Tsai, et al.. (2021). The Association of Urinary Sclerostin and Renal Magnesium Handling in Type 2 Diabetic Patients with Chronic Kidney Disease. Kidney & Blood Pressure Research. 46(4). 514–522. 2 indexed citations
12.
Wang, Hsi‐Hao, Jia‐Ling Wu, Yi‐Che Lee, et al.. (2020). Risk of Serious Falls Between Hemodialysis and Peritoneal Dialysis Patients: A Nationwide Population-based Cohort Study. Scientific Reports. 10(1). 7799–7799. 11 indexed citations
13.
Lee, Yi‐Che, Fong‐Yu Cheng, Shih‐Yuan Hung, et al.. (2019). <p>The Clinical Implication of Vitamin D Nanomedicine for Peritoneal Dialysis-Related Peritoneal Damage</p>. International Journal of Nanomedicine. Volume 14. 9665–9675. 6 indexed citations
14.
Wang, Jiun‐Ling, et al.. (2015). Daily chlorhexidine care at exit site in patients with peritoneal dialysis: A randomized control trial. Journal of Microbiology Immunology and Infection. 48(2). S57–S58. 3 indexed citations
15.
Lee, Yi‐Che, Shih‐Yuan Hung, Hsi‐Hao Wang, et al.. (2015). Different Risk of Common Gastrointestinal Disease Between Groups Undergoing Hemodialysis or Peritoneal Dialysis or With Non-End Stage Renal Disease. Medicine. 94(36). e1482–e1482. 39 indexed citations
16.
Lee, Yi‐Che, Jyh‐Seng Wang, Ming-Kai Tsai, et al.. (2014). Haemolytic uremic syndrome following fire ant bites. BMC Nephrology. 15(1). 5–5. 11 indexed citations
17.
Hung, Shih‐Yuan, Tsun‐Mei Lin, Min-Yu Chang, et al.. (2014). Risk factors of sensitization to human leukocyte antigen in end-stage renal disease patients. Human Immunology. 75(6). 531–535. 22 indexed citations
18.
Ho, Li‐Chun, Junne‐Ming Sung, Yau-Sheng Tsai, et al.. (2014). Cystatin C as a Predictor for Outcomes in Patients with Negligible Renal Function. Blood Purification. 38(2). 81–88. 4 indexed citations
19.
Lee, Yi‐Che, Yau-Sheng Tsai, Shih‐Yuan Hung, et al.. (2014). Shorter daily dwelling time in peritoneal dialysis attenuates the epithelial-to-mesenchymal transition of mesothelial cells. BMC Nephrology. 15(1). 35–35. 9 indexed citations
20.
Kirchgessner, Judith, et al.. (2003). Survey of medical data from data acquisition to high quality patient treatment. 2. 378–381. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aleksandra Wyczałkowska-Tomasik Breakdown of academic impact, for papers by Angie D. Fulford Breakdown of academic impact, for papers by Martine Laville Breakdown of academic impact, for papers by Jean‐Pierre Ferré Breakdown of academic impact, for papers by Triantafillia Dimitriou Breakdown of academic impact, for papers by Anjuman Ara Mimi Breakdown of academic impact, for papers by Ömer Azal Breakdown of academic impact, for papers by A. E. Lambert Breakdown of academic impact, for papers by Özgür Yörük Breakdown of academic impact, for papers by S. Güler
Rankless by CCL
2026